Envoy Medical, Inc. (COCH)
NASDAQ: COCH · IEX Real-Time Price · USD
2.240
-0.040 (-1.75%)
At close: Jul 19, 2024, 4:30 PM
2.320
+0.080 (3.57%)
Pre-market: Jul 20, 2024, 9:28 AM EDT
Envoy Medical Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Envoy Medical stock have an average target of 7.25, with a low estimate of 6.00 and a high estimate of 8.50. The average target predicts an increase of 223.66% from the current stock price of 2.24.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Envoy Medical stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Initiates $8.5 | Strong Buy | Initiates | $8.5 | +279.46% | Jun 24, 2024 |
| Lake Street | Lake Street | Strong Buy Maintains $3 → $6 | Strong Buy | Maintains | $3 → $6 | +167.86% | Apr 3, 2024 |
| Northland Capital Markets | Northland Capital Markets | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Dec 21, 2023 |
| Lake Street | Lake Street | Strong Buy Initiates $3 | Strong Buy | Initiates | $3 | +33.93% | Nov 28, 2023 |
Financial Forecast
Revenue This Year
408.00K
from 316.00K
Increased by 29.11%
Revenue Next Year
408.00K
from 408.00K
EPS This Year
-1.15
from -2.38
EPS Next Year
-1.16
from -1.15
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 420,000 | 420,000 | 2.9M |
| Avg | 408,000 | 408,000 | 2.9M |
| Low | 392,000 | 392,000 | 2.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 32.9% | 2.9% | 620.6% |
| Avg | 29.1% | - | 600.0% |
| Low | 24.1% | -3.9% | 572.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.19 | -1.20 | -0.59 |
| Avg | -1.15 | -1.16 | -0.57 |
| Low | -1.11 | -1.12 | -0.55 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.